DLA
GSK icon

Douglas Lane & Associates’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$50.6M Sell
1,317,109
-204,417
-13% -$7.85M 0.73% 55
2025
Q1
$58.9M Sell
1,521,526
-106,978
-7% -$4.14M 0.87% 46
2024
Q4
$55.1M Sell
1,628,504
-544,979
-25% -$18.4M 0.78% 48
2024
Q3
$88.9M Sell
2,173,483
-34,927
-2% -$1.43M 1.22% 27
2024
Q2
$85M Sell
2,208,410
-12,141
-0.5% -$467K 1.21% 24
2024
Q1
$95.2M Sell
2,220,551
-15,613
-0.7% -$669K 1.35% 21
2023
Q4
$82.9M Sell
2,236,164
-75,727
-3% -$2.81M 1.28% 26
2023
Q3
$83.8M Buy
2,311,891
+87,789
+4% +$3.18M 1.41% 21
2023
Q2
$79.3M Buy
2,224,102
+61,812
+3% +$2.2M 1.28% 28
2023
Q1
$76.9M Buy
2,162,290
+108,193
+5% +$3.85M 1.28% 29
2022
Q4
$72.2M Buy
2,054,097
+464,538
+29% +$16.3M 1.21% 35
2022
Q3
$46.8M Sell
1,589,559
-248,476
-14% -$7.31M 0.86% 46
2022
Q2
$80M Buy
1,838,035
+43,756
+2% +$1.9M 1.36% 24
2022
Q1
$78.2M Buy
1,794,279
+52,032
+3% +$2.27M 1.1% 33
2021
Q4
$76.8M Buy
1,742,247
+93,958
+6% +$4.14M 1.02% 33
2021
Q3
$63M Buy
1,648,289
+166,794
+11% +$6.37M 0.9% 42
2021
Q2
$59M Buy
1,481,495
+137,474
+10% +$5.47M 0.83% 47
2021
Q1
$48M Buy
1,344,021
+177,361
+15% +$6.33M 0.74% 56
2020
Q4
$42.9M Buy
1,166,660
+78,437
+7% +$2.89M 0.72% 53
2020
Q3
$41M Buy
1,088,223
+142,252
+15% +$5.35M 0.81% 47
2020
Q2
$38.6M Buy
945,971
+81,965
+9% +$3.34M 0.83% 46
2020
Q1
$32.7M Buy
864,006
+118,400
+16% +$4.49M 0.86% 45
2019
Q4
$35M Buy
745,606
+338,569
+83% +$15.9M 0.65% 61
2019
Q3
$17.4M Buy
+407,037
New +$17.4M 0.35% 85